Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Pancreatic Cancer Clinical Trials
Pancreatic Cancer clinical trials are recruiting across 159 cities. Here are the cities with the most active studies:
Pancreatic Cancer Trial Phases
65 research organizations are sponsoring pancreatic cancer trials.
About Pancreatic Cancer
Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.
Clinical trials are advancing new treatments for pancreatic cancer. Currently, 100 studies are recruiting a combined 1,135,905 participants across the United States. Research is being conducted by 65 organizations including University of Nebraska, Mayo Clinic, Arbor Research Collaborative for Health and 62 others.
2026 Pancreatic Cancer Research Landscape
As of October 2026, the pancreatic cancer clinical trial landscape includes 100 actively recruiting studies across 159 cities in the United States. These studies are collectively seeking 1,135,905 participants, with an average enrollment target of 11,359 per study.
The research spans multiple phases of development: 30 studies are in PHASE2, 17 studies are in NA, 17 studies are in PHASE1, 16 studies are in PHASE3, 3 studies are in EARLY_PHASE1. The presence of Phase 3 trials indicates that some pancreatic cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 65 different organizations, including University of Nebraska, Mayo Clinic, Arbor Research Collaborative for Health, Johns Hopkins University, University of Pittsburgh, and 60 others. The large number of sponsors reflects significant research interest and investment in pancreatic cancer treatment advancement.
Geographically, pancreatic cancer trials are most concentrated in Los Angeles, California (16 trials); Boston, Massachusetts (15 trials); New York, New York (14 trials); Rochester, Minnesota (12 trials); Phoenix, Arizona (11 trials) and 7 other cities.
Featured Pancreatic Cancer Studies
Highlighted recruiting studies for pancreatic cancer, selected by enrollment size and research scope.
Integrated Cancer Repository for Cancer Research
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rur...
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders...
Frequently Asked Questions About Pancreatic Cancer Clinical Trials
Are there pancreatic cancer clinical trials near me?
Yes, there are 100 pancreatic cancer clinical trials currently recruiting across 159+ cities in the United States, including Los Angeles, California; Boston, Massachusetts; New York, New York. Browse the studies above to find one at a location convenient for you.
How do I join a pancreatic cancer clinical trial?
To join a pancreatic cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pancreatic cancer clinical trials free?
Yes, participation in pancreatic cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pancreatic cancer treatments are being studied?
Current pancreatic cancer clinical trials are testing a range of approaches across PHASE2 (30 studies), NA (17 studies), PHASE1 (17 studies), PHASE3 (16 studies), EARLY_PHASE1 (3 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 65 research organizations.
Is it safe to participate in pancreatic cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated October 19, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated October 19, 2026 · Data from ClinicalTrials.gov